On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Newsletter Signup

Every Stocks to Buy Now newsletter highlights one primary and high-potential play we’ve been watching for a while, as well as several additional undervalued stocks we believe are worth a second glance. We’ll save you the step of mining the market for potential plays and deliver fresh opportunities right to your inbox.

You’re just a click and email verification away from joining hundreds of other subscribers receiving weekly trading ideas and the right stocks to buy now!

P.S. We will never spam you or sell your information.

 

 

 

From Our Blog

Lexaria Bioscience Corp. (NASDAQ: LEXX) Grows Global Patent Portfolio to 41; Maintains Focus on GLP-1 Clinical Studies for 2024

April 16, 2024

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, in the month of April 2024, added three new patents to its portfolio. This brings the total number of awarded patents globally to 41, a testament to the versatility of its patented DehydraTECH(TM) technology and its overall viability in the potential treatment of various […]

Rotate your device 90° to view site.